Jambur Ananth

1.9k total citations
57 papers, 1.4k citations indexed

About

Jambur Ananth is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Jambur Ananth has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Psychiatry and Mental health, 13 papers in Clinical Psychology and 12 papers in Pharmacology. Recurrent topics in Jambur Ananth's work include Schizophrenia research and treatment (13 papers), Electroconvulsive Therapy Studies (11 papers) and Obsessive-Compulsive Spectrum Disorders (9 papers). Jambur Ananth is often cited by papers focused on Schizophrenia research and treatment (13 papers), Electroconvulsive Therapy Studies (11 papers) and Obsessive-Compulsive Spectrum Disorders (9 papers). Jambur Ananth collaborates with scholars based in United States, Canada and Ecuador. Jambur Ananth's co-authors include Karl Burgoyne, Sarath Gunatilake, F. Engelsmann, Kyle B. Boone, Linda Philpott, Sharat Parameswaran, John C. Pecknold, Keh‐Ming Lin, A.M. Ghadirian and Milton H. Miller and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Jambur Ananth

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jambur Ananth United States 19 744 483 238 221 181 57 1.4k
Ananda K. Pandurangi United States 19 1.1k 1.5× 446 0.9× 176 0.7× 183 0.8× 237 1.3× 56 1.8k
David G. Folks United States 24 621 0.8× 328 0.7× 137 0.6× 105 0.5× 122 0.7× 56 1.3k
J. Peuskens Belgium 29 1.7k 2.3× 662 1.4× 219 0.9× 126 0.6× 141 0.8× 87 2.6k
Eileen P. Ahearn United States 21 887 1.2× 556 1.2× 221 0.9× 141 0.6× 152 0.8× 36 1.6k
J.C. Ballenger United States 20 565 0.8× 571 1.2× 184 0.8× 348 1.6× 131 0.7× 66 1.7k
Joachim Cordes Germany 20 722 1.0× 361 0.7× 214 0.9× 193 0.9× 297 1.6× 51 1.6k
Eileen Brown United States 16 569 0.8× 545 1.1× 218 0.9× 118 0.5× 60 0.3× 31 2.0k
Sook-Haeng Joe South Korea 23 513 0.7× 306 0.6× 117 0.5× 173 0.8× 190 1.0× 52 1.5k
R. Buller Germany 12 307 0.4× 420 0.9× 193 0.8× 527 2.4× 191 1.1× 34 1.2k
Lawrence A. Labbate United States 25 670 0.9× 537 1.1× 235 1.0× 240 1.1× 163 0.9× 54 1.8k

Countries citing papers authored by Jambur Ananth

Since Specialization
Citations

This map shows the geographic impact of Jambur Ananth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jambur Ananth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jambur Ananth more than expected).

Fields of papers citing papers by Jambur Ananth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jambur Ananth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jambur Ananth. The network helps show where Jambur Ananth may publish in the future.

Co-authorship network of co-authors of Jambur Ananth

This figure shows the co-authorship network connecting the top 25 collaborators of Jambur Ananth. A scholar is included among the top collaborators of Jambur Ananth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jambur Ananth. Jambur Ananth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ananth, Jambur, et al.. (2005). Atypical antipsychotic drugs, diabetes and ethnicity. Expert Opinion on Drug Safety. 4(6). 1111–1124. 16 indexed citations
2.
Ananth, Jambur, et al.. (2005). Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?. Expert Opinion on Drug Safety. 4(1). 55–68. 9 indexed citations
3.
Ananth, Jambur, et al.. (2004). A typical Antipsychotic Induced Weight Gain: Pathophysiology and Management. Annals of Clinical Psychiatry. 16(2). 75–85. 56 indexed citations
4.
Ananth, Jambur, et al.. (2003). Pharmacotherapy for refractory schizophrenia patients. Expert Review of Neurotherapeutics. 3(3). 387–401. 1 indexed citations
5.
Ananth, Jambur, et al.. (2002). Atypical Antipsychotic Drug Use and Diabetes. Psychotherapy and Psychosomatics. 71(5). 244–254. 45 indexed citations
6.
Ananth, Jambur, et al.. (1999). Olanzapine Treatment After Clozapine-Induced Granulocytopenia in 3 Patients. The Journal of Clinical Psychiatry. 60(2). 119–121. 8 indexed citations
7.
Burgoyne, Karl, et al.. (1997). Tardive dyskinesia and ethnicity: review of the literature.. Annals of Clinical Psychiatry. 9(1). 53–59. 28 indexed citations
8.
Burgoyne, Karl, et al.. (1995). Porphyria: Reexamination of Psychiatric Implications. Psychotherapy and Psychosomatics. 64(3-4). 121–130. 32 indexed citations
9.
Rubín, Robert T., et al.. (1995). Regional 133Xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biological Psychiatry. 38(7). 429–437. 65 indexed citations
10.
Ananth, Jambur, et al.. (1994). Hepatic Disease and Psychiatric Illness: Relationships and Treatment. Psychotherapy and Psychosomatics. 62(3-4). 146–159. 11 indexed citations
11.
Ananth, Jambur, et al.. (1993). Rapid Cycling Patients: Conceptual and Etiological Factors. Neuropsychobiology. 27(4). 193–198. 12 indexed citations
12.
Ananth, Jambur & Karen A. Johnson. (1992). Psychotropic and Medical Drug Interactions. Psychotherapy and Psychosomatics. 58(3-4). 178–196. 4 indexed citations
13.
Ananth, Jambur. (1992). Psychopharmacological Agents in Physical Disorders. Psychotherapy and Psychosomatics. 58(1). 13–31. 4 indexed citations
14.
Ananth, Jambur, et al.. (1992). Physical Illness in Hospitalized Psychiatric Patients. Annals of Clinical Psychiatry. 4(2). 99–104. 1 indexed citations
15.
Pi, Edmond H., John J. Sramek, John M. Herrera, et al.. (1990). Subjective neuroleptic response and treatment outcome under open and double-blind conditions — A preliminary report. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 14(6). 921–928. 6 indexed citations
16.
Ananth, Jambur, et al.. (1989). Rapid Tranquilization: A Reevaluation. Neuropsychobiology. 22(2). 90–96. 9 indexed citations
17.
Ananth, Jambur, et al.. (1989). Missed Diagnosis of Substance Abuse in Psychiatric Patients. Psychiatric Services. 40(3). 297–299. 127 indexed citations
18.
Johnson, R. A. & Jambur Ananth. (1987). The newer antidepressants: Promises and realities. Comprehensive Psychiatry. 28(6). 488–498. 1 indexed citations
19.
Ananth, Jambur. (1987). Benzodiazepines: selective administration. Journal of Affective Disorders. 13(2). 99–108. 1 indexed citations
20.
Ananth, Jambur & Keh‐Ming Lin. (1986). Propranolol in Psychiatry. Neuropsychobiology. 15(1). 20–27. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026